Open Access

Rhodiola rosea, folic acid, zinc and biotin (EndEP®) is able to improve ejaculatory control in patients affected by lifelong premature ejaculation: Results from a phase I‑II study

  • Authors:
    • Tommaso Cai
    • Paolo Verze
    • Paolo Massenio
    • Daniele Tiscione
    • Gianni Malossini
    • Luigi Cormio
    • Giuseppe Carrieri
    • Vincenzo Mirone
  • View Affiliations

  • Published online on: August 12, 2016     https://doi.org/10.3892/etm.2016.3595
  • Pages: 2083-2087
  • Copyright: © Cai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The therapeutic armamentarium currently available for the treatment of premature ejaculation (PE) is not highly satisfactory. However, phytotherapeutics appear to be an interesting option for PE management. The present study aimed to evaluate the tolerability and efficacy of a phytotherapeutic combination of Rhodiola rosea, folic acid, biotin and zinc (EndEP®) in the treatment of patients affected by lifelong PE. All patients affected by lifelong PE who were attending three Urological Institutions from July to December 2014 were enrolled in this prospective, multicentre, phase I‑II study. All patients were assigned to receive oral tablets of EndEP® (one tablet per day) for 90 days. Clinical and instrumental analyses were carried out at enrolment and at the end of the study. International Prostatic Symptom Score (IPSS), International Index of Erectile Function (IIEF)‑15, Premature Ejaculation Diagnostic Tool (PEDT) and Short Form (SF)‑36 questionnaires were used. The intravaginal ejaculation latency time (IELT) for each event was also evaluated using the stop‑watch technique. The main outcome measure was the difference from baseline in PEDT questionnaire and mean IELT at the end of the follow‑up period. In total, 91 patients (mean age, 32.3±5.6 years) were analysed. The baseline questionnaires mean scores were 1.1±1.6, 26.1±2.9, 15.3±3.4 and 98.2±0.5, for IPSS, IIEF‑15, PEDT and SF‑36, respectively. The mean IELT at baseline was 73.6±46.9s. At the follow‑up examination (90 days after the start of treatment), no statistically significant differences were identified in terms of IPSS (1.4±1.5) or IIEF‑15 (26.3±3.1) compared with the pre‑treatment values (P=0.19 and P=0.64, respectively). A statistically significant difference was detected between the mean IELT at enrolment and after treatment (73.6±46.9 vs. 102.3±60.0; P<0.001) and SF‑36 questionnaire (98.2±0.5 vs. 99.4±0.1; P<0.001). Fifty‑five patients reported improvement in the control of ejaculation (60.4%). Very few adverse events were reported (4.4%). In conclusion, it was found that EndEP® significantly improved ejaculatory control and the quality of sexual life in patients affected by lifelong PE, with a very low rate of adverse events.
View Figures
View References

Related Articles

Journal Cover

October-2016
Volume 12 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

The Cancer Story
Copy and paste a formatted citation
x
Spandidos Publications style
Cai T, Verze P, Massenio P, Tiscione D, Malossini G, Cormio L, Carrieri G and Mirone V: Rhodiola rosea, folic acid, zinc and biotin (EndEP®) is able to improve ejaculatory control in patients affected by lifelong premature ejaculation: Results from a phase I‑II study. Exp Ther Med 12: 2083-2087, 2016
APA
Cai, T., Verze, P., Massenio, P., Tiscione, D., Malossini, G., Cormio, L. ... Mirone, V. (2016). Rhodiola rosea, folic acid, zinc and biotin (EndEP®) is able to improve ejaculatory control in patients affected by lifelong premature ejaculation: Results from a phase I‑II study. Experimental and Therapeutic Medicine, 12, 2083-2087. https://doi.org/10.3892/etm.2016.3595
MLA
Cai, T., Verze, P., Massenio, P., Tiscione, D., Malossini, G., Cormio, L., Carrieri, G., Mirone, V."Rhodiola rosea, folic acid, zinc and biotin (EndEP®) is able to improve ejaculatory control in patients affected by lifelong premature ejaculation: Results from a phase I‑II study". Experimental and Therapeutic Medicine 12.4 (2016): 2083-2087.
Chicago
Cai, T., Verze, P., Massenio, P., Tiscione, D., Malossini, G., Cormio, L., Carrieri, G., Mirone, V."Rhodiola rosea, folic acid, zinc and biotin (EndEP®) is able to improve ejaculatory control in patients affected by lifelong premature ejaculation: Results from a phase I‑II study". Experimental and Therapeutic Medicine 12, no. 4 (2016): 2083-2087. https://doi.org/10.3892/etm.2016.3595